276
Views
1
CrossRef citations to date
0
Altmetric
Review

Signaling Pathways Involved in 5-FU Drug Resistance in Cancer

ORCID Icon, ORCID Icon & ORCID Icon
Pages 516-543 | Received 25 Oct 2020, Accepted 14 Mar 2022, Published online: 28 Mar 2022
 

Abstract

Anti-metabolite drugs prevent the synthesis of essential cell growth compounds. 5-fluorouracil is used as an anti-metabolic drug in various cancers in the first stage of treatment. Unfortunately, in some cancers, 5-fluorouracil has low effectiveness because of its drug resistance. Studies have shown that drug resistance to 5-fluorouracil is due to the activation of specific signaling pathways and increased expressions of enzymes involved in drug metabolites. However, when 5-fluorouracil is used in combination with other drugs, the sensitivity of cancer cells to 5-fluorouracil increases, and the effect of drug resistance is reversed. This study discusses how the function of 5-fluorouracil in JAK/STAT, Wnt, Notch, NF-κB, and hedgehogs in some cancers.

Acknowledgments

A sincere thank you to Naser Danesh Pouya for his diligent proofreading of this study.

Author contributions

Fahima Danesh Pouya and Yousef Rasmi designed the study; Fahima Danesh Pouya wrote and revised the manuscript draft; Yousef Rasmi and Mohadeseh Nemati critically reviewed the manuscript. All authors approved the final version of the manuscript.

Disclosure statement

The authors declare that there are no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.